Using QI to develop a sustainable method for titrating taxane infusions to reduce hypersensitivity reactions

Area of Science:

• Oncology
• Pharmacology
• Quality Improvement

Background:

• Taxane chemotherapy can cause hypersensitivity reactions (HSRs), necessitating careful administration.
• Existing titration methods may pose patient and environmental safety risks.
• Optimizing taxane infusion protocols is crucial for safe and effective cancer treatment.

Purpose of the Study:

• To develop a sustainable three-step titration method for taxane administration.
• To integrate patient and environmental safety best practices into the titration process.
• To evaluate the impact of this new method on immediate HSR rates.

Main Methods:

• A quality improvement study was conducted at a comprehensive cancer center.
• Retrospective data from 690 patients receiving 1221 taxane doses were analyzed.
• Infusions were compared across non-titrated, initial titration, and revised titration groups using Fisher's exact tests.

Main Results:

• The revised three-step titration method, using standardized rates and pre-primed tubing, reduced HSR incidence to 6%.
• This was a significant reduction compared to non-titrated infusions (19%, P=0.001).
• The revised method's HSR rate was comparable to a previously studied but unsustainable method (6% vs. 7%).

Conclusions:

• A sustainable three-step taxane titration method was successfully developed and implemented.
• This method significantly reduces taxane-related HSRs.
• The practice was adopted for ambulatory cancer care, improving patient safety.